Rocket


Overview
Financials
News + Filings
Key Docs
Ownership


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
ADC Therapeutics SA Create: Alert

All | News | Filings
Date FiledTypeDescription
08/08/2023 6-K Quarterly results
Docs: "6-K",
"Unaudited IFRS Condensed Consolidated Interim Financial Statements",
"MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS",
"ADC Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update"
07/20/2023 6-K Quarterly results
07/11/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K"
05/09/2023 6-K Quarterly results
Docs: "6-K",
"Unaudited IFRS Condensed Consolidated Interim Financial Statements",
"MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS",
"ADC Therapeutics Reports First Quarter 2023 Financial Results and Provides Business and Strategy Update"
05/05/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Invitation to the Annual General Meeting",
"ADC Therapeutics SA Shareholder Meeting Notice",
"Annual General Meeting Proxy Card (Record Holders)",
"Annual General Meeting Proxy Card (Brokers)"
03/15/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "2022 Annual Report",
"2022 Annual Report"
03/13/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K"
02/28/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K"
02/06/2023 6-K Quarterly results
02/02/2023 6-K Quarterly results
01/09/2023 6-K Quarterly results
01/04/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"ADC Therapeutics Appoints Mohamed Zaki as Chief Medical Officer"
01/04/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"ADC Therapeutics to Participate in the 41st Annual J.P. Morgan Healthcare Conference"
12/21/2022 6-K Quarterly results
12/19/2022 6-K Quarterly results
11/08/2022 6-K Quarterly results
Docs: "6-K",
"Unaudited IFRS Condensed Consolidated Interim Financial Statements",
"MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS",
"ADC Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates"
11/07/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"ADC Therapeutics to Participate in the Jefferies London Healthcare Conference"
11/03/2022 6-K Quarterly results
11/02/2022 6-K Quarterly results
11/01/2022 6-K Quarterly results
10/31/2022 6-K Quarterly results
09/16/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K"
09/07/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"ADC Therapeutics to Participate in Morgan Stanley’ s 20 th Annual Global Healthcare Conference"
08/15/2022 6-K Quarterly results
08/09/2022 6-K Quarterly results
08/02/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"ADC Therapeutics to Host Second Quarter 2022 Financial Results Conference Call on August 9, 2022"
07/27/2022 6-K Quarterly results
07/20/2022 6-K Quarterly results
07/11/2022 6-K Quarterly results
07/11/2022 6-K Quarterly results
06/30/2022 6-K Quarterly results
06/29/2022 6-K Quarterly results
06/13/2022 6-K Quarterly results
06/10/2022 6-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy